Empirical Antibiotic and Outcome in Community-onset Bacteremia

Completed

• Conditions: Bacteremia

• Registration Number: NCT03765749
• Lead Sponsor: Phramongkutklao College of Medicine and Hospital

Brief Summary

Empirical antibiotic and outcome in Community-onset Bacteremia Caused by third generation cephalosporin resistant Enterobacteriaceae

Detailed Description

Prospective cohort study is conducted for monitoring outcomes and risk factors among community-onset bacteremia caused by third generation cephalosporin resistant enterobacteriaceae.

Primary endpoint is mortality rate among those who received initially inappropriate antimicrobial which switch to appropriate antimicrobial later when culture and antimicrobial susceptibility test reported among community-onset bacteremia caused by third generation cephalosporin resistant enterobacteriaceae.

Study Timeline

• Study First Submitted: 2018-03-22
• Study Start: 2018-11-22
• Study First Submitted QC: 2018-12-03
• Study First Posted: 2018-12-05
• Primary Completion: 2021-12-31
• Study Completion: 2021-12-31
• Status Verified: 2022-04
• Last Update Submitted: 2022-04-18
• Last Update Posted: 2022-04-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

• Patient with Community-onset Bacteremia Caused by third generation cephalosporin resistant Enterobacteriaceae. Age > 18 years

Exclusion Criteria

• Pregnancy
• Polymicrobial infection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality rate among community-onset bacteremia caused by third generation cephalosporin resistant enterobacteriaceae	January 2018 - march 2019

Trial Locations

Locations (1)

Worapong Nasomsong; 🇹🇭 Bangkok, Thailand